How to deal with prognostic factors and radiotherapy results in uterine neoplasms with a sarcomatous component?

Clinical and Translational Oncology

Volumn 11, Issue 10, 2009, Pages 681-687

  Rovirosa, Ángeles ^a   Ascaso, Carlos ^a   Ordi, Jaume ^a   Arenas, Meritxell ^b   Valduvieco, Izaskun ^a   Lejarcegui, José Antonio ^a   Pahisa, Jaume ^a   Torne, Aureli ^a   Biete, Albert ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b Medical Oncology Department   (Spain)

Author keywords

Prognostic factors; Radiotherapy; Uterine sarcomas

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOSARCOMA; FEMALE; HUMAN; LEIOMYOSARCOMA; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; UTERUS CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOSARCOMA; FEMALE; HUMANS; LEIOMYOSARCOMA; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 75349102184     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-009-0424-9     Document Type: Conference Paper

References (34)

1. Rovirosa A (2006) Uterine tumours with sarcomatous component. Past, present and future. Oncologia 29:277-282
2. Reed NS, Mangioni C, Malmström H et al (2008) Phase III randomised study to evaluate the role of adjuvant radiotherapy in the treatment of uterine sarcomas stages I and II: a European organisation for research and treatment of cancer Gynaecological Cancer Group study (protocol 55874). Eur J Cancer 44:808-818
3. Rovirosa A (2001) Sarcomas Uterinos. In: Cabero Ll, Iglesias X, Balagueró L., Xercavins J (eds) Ginecología Oncológica. Ediciones Ergon, Madrid, pp 177-187
4. Jou P, González Bosquet E, Rovirosa A (2000) Sarcomas y tumores müllerianos mixtos malignos de útero. In: González-Merlo J, Gonzalez Bosquet J (eds) Ginecología Oncológica, 2nd Edn. Ed. Masson, Barcelona, pp 283-306
5. Brooks SE, Zhan M, Coe T, Baquet CR (2004) Surveillance, epidemiology and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol 93:204-208
6. Rovirosa A, Ascaso C, Ordi J et al (2002) Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratifi ed by stages. Int J Radiat Oncol Biol Phys 52:1320-1329
7. (2002) TNM/UICC classifi cation for malignant tumours, 6th Edn. Wilely-Liss, New York
8. Silverberg SG, Kurman RJ (1991) Tumours of the uterine corpus and gestational trophoblastic disease. In: Rosai J (ed.) Atlas of tumour pathology, 3rd series. Armed Forces Institute of Pathology, Washington, DC, pp 13-14
9. Cox DR, Oakes D (1984) Analysis of survival data. Chapman & Hall, London
10. Armitage P, Berry G (1992) Estadística para la investigación biomédica. Doyma, Barcelona
11. Stefansson IM, Salvensen HB, Immervoll H, Akslen LA (2004) Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma endometrioid type. Histopathology 44:472-479
12. Rovirosa A, Ordi J, Ascaso C et al (1998) Prognostic factors in uterine sarcomas: a retrospective study of 21 years at the Hospital Clínica i Provincial de Barcelona. Med Clin (Barc) 111:172-176
13. Nielsen SN, Podratz K, Scheithauer BW, O'Brien PC (1989) Clinicopathologic analyses of uterine malignant mixed müllerian tumors. Gynecol Oncol 34:372-378
14. Arrastia CD, Fruchter RG, Clark M et al (1997) Uterine sarcomas: incidence and trends in man agement and survival. Gynecol Oncol 65:158-163
15. Moskovic E, Macsweeney E, Law M, Price A (1993) Survival, patterns of spread and prognostic factors in uterine sarcoma: a study of 76 patients. Br J Radiol 66:1009-1015
16. Gadducci A, Landoni F, Sartori E et al (1996) Uterine leiomyosarcoma: analysis of treatment failures and survival. Gynecol Oncol 62:25-32
17. Pautier P, Genestie C, Rey A et al (2000) Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer 88:1425-1431
18. Vongtama V, Karlen JR, Piver SM et al (1976) Treatment, results and prognosis factors in stage I and II sarcomas of the corpus uteri. Am J Roentgenol 126:139-147
19. Major FJ, Blessing JA, Silverber SG et al (1993) Prognostic factors in early stages uterine sarcoma. A Gynecologic Oncologic Group Study. Cancer 71:1702-1709
20. Chiara S, Foglia G, Odicino F et al (1988) Uterine sarcomas: a clinicopathological study. Oncology 45:428-433
21. Mayerhofer K, Obermair A, Windbichler G et al (1999) Leiomyoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol 74:196-201
22. Yamada SD, Burguer RA, Brewster WR et al (2000) Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients surgically evaluated carcinosarcoma of the uterus. Cancer 88:2782-2786
23. McGinn CJ (2004) Soft tissue sarcomas. In: Perez CA, Brady LH, Halperin EC, Schmidt-Ullrich RK (eds) Principles and practice of radiation oncology, 4th Edn. Lippincot Williams & Wilkins, USA, pp 2185-2205
24. Olah KS, Gee H, Blunt S et al (1991) Retrospective study of 318 cases of uterine sarcoma. Eur J Cancer 27:1095-1099
25. Olah KS, Blunt S, Gee H et al (1992) Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumors when adjusting for known prognostic factors: the result of a sarcoma. Br J Obstet Gynecol 99:590-594
26. Chauvenic L, Deniaud E, Plancher C et al (1999) Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments. Gynecol Oncol 72:232-237
27. Livi L, Pajar F, Shah N et al (2003) Uterine sarcoma: twenty-seven years of experience. Int J Radiation Oncol Biol Phys 57:1366-1373
28. Denschlag D, Masoud I, Stanimir G, Gilbert L (2007) Prognostic factors and outcome in women with uterine sarcoma. Eur J Surg Oncol 33:91-95
29. Dusembery KE, Potish RA, Judson P (2004) Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus. Gynecol Oncol 94:191-196
30. Sartori E, Bazzurinni L, Gadduci A et al (1997) Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study. Gynecol Oncol 67:70-75
31. Omura GA, Blessing J, Major F et al (1985) A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a gynaecologic oncology group study. J Clin Oncol 3:1240-1245
32. Tierney J (1999) Adjuvant chemotherapy for localized resectable soft tissue sarcoma in adults, in the Cochrane database of the systemic reviews. Cochrane Library 2:1-30
33. Kajeekal S, Chambers A, Fung FK, Verma S (2005) Systemic therapy for advanced uterine sarcoma: a systematic review of the literature. Gynecol Oncol 97:624-637
34. Gadduci A, Cosio S, Romanini A, Genazzani AR (2008) The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Haematol (65):129-142